Bafna Pharmaceuticals Shareholding

Bafna Pharmaceuticals Ltd Shareholding Pattern

The Bafna Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Bafna Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Bafna Pharmaceuticals Ltd (NSE: BAFNAPH, BSE: 532989) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Bafna Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Bafna Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Bafna Pharmaceuticals Ltd shareholding for Dec 2025 is:

• Promoters: 75%
• FII: 9.34%
• DII: 0%
• Public: 15.66%
• Government: 0%

Promoter holding in Bafna Pharmaceuticals Ltd remains stable, reflecting consistent long-term commitment.

Bafna Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Bafna Pharmaceuticals Ltd.

• Dec 2025: 75%
• Sept 2025: 75%
• Jun 2025: 75%
• Mar 2025: 75%
• Dec 2024: 88.30%

Promoter stake remains largely stable, showing consistent ownership structure.

Bafna Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Bafna Pharmaceuticals Ltd.

• Dec 2025: 9.34%
• Sept 2025: 9.34%
• Jun 2025: 9.34%
• Mar 2025: 8.53%
• Dec 2024: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Bafna Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

DII holdings remain stable, reflecting steady institutional participation.

Bafna Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 15.66%
• Sept 2025: 15.66%
• Jun 2025: 15.66%
• Mar 2025: 16.47%
• Dec 2024: 11.70%

Public holding remains stable with consistent retail participation.

Bafna Pharmaceuticals Ltd Government Holding

Government holding in Bafna Pharmaceuticals Ltd currently stands at 0%.

Bafna Pharmaceuticals Ltd operates without significant government ownership.

Bafna Pharmaceuticals Ltd Shareholding Analysis Summary

The Bafna Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Bafna Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Bafna Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.